The UK's developing landscape of copyright substances is witnessing a remarkable shift, extending far beyond the traditional focus on psilocybin and LSD . Interest is increasingly centered on newer compounds, including the potent hallucinogen , CBG a cannabinoid showing potential therapeutic propert